The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 study of bizaxofusp, an IL-4R targeted toxin payload, in nonresectable recurrent GBM: Comparison of overall survival with contemporaneous eligibility-matched and propensity score balanced external control arm.
 
John H. Sampson
Leadership - Medicenna
Stock and Other Ownership Interests - Annias Immunotherapeutics; Immunomic Therapeutics; Insera Health; ISTARI Oncology; Neuronium
Research Funding - Annias Immunotherapeutics; ISTARI Oncology
Patents, Royalties, Other Intellectual Property - Annias Immunotherapeutics; ISTARI Oncology; Neuronium
Other Relationship - Annias Immunotherapeutics; Celldex
 
Martin Bexon
Consulting or Advisory Role - Medicenna
 
Steven Brem
No Relationships to Disclose
 
Andrew J. Brenner
Leadership - NanoTX
Stock and Other Ownership Interests - NanoTX; Plus Therapeutics
Honoraria - Seagen; Vascular Biogenics
Consulting or Advisory Role - Alamab Therapeutics; NanoTX; Plus Therapeutics; Vascular Biogenics
Research Funding - Gilead Sciences (Inst); Immunomedics (Inst); Plus Therapeutics (Inst); Upsher-Smith (Inst)
Patents, Royalties, Other Intellectual Property - I have intellectual property interest in NanoTx Therapeutics
Travel, Accommodations, Expenses - Vascular Biogenics
 
Melissa Coello
Employment - Medicenna
Stock and Other Ownership Interests - Medicenna
 
Sunit Das
Consulting or Advisory Role - Subcortical Surgery Group; Xpan Medical
Speakers' Bureau - American Association of Neurological Surgeons; Congress of Neurological Surgeons
Research Funding - Alkermes (Inst)
Patents, Royalties, Other Intellectual Property - I receive royalties from Oxford University Press.
Travel, Accommodations, Expenses - Congress of Neurological Surgeons; Subcortical Surgery Group
Other Relationship - Cancer Care Ontario
 
Ruthie Davi
Employment - Medidata
Stock and Other Ownership Interests - Dassault Systemes
Research Funding - Medidata
Travel, Accommodations, Expenses - Medidata
 
Annick Desjardins
Stock and Other Ownership Interests - ISTARI Oncology
Consulting or Advisory Role - Biodexa; Orbus Therapeutics
Research Funding - Biodexa (Inst); Orbus Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - AU 2019247039 NEOADJUVANT CANCER TREATMENT; CA 2,892,183 - Method of Treating Solid Tumor w/Oncolytic Poliovirus licensed to Istari, a patent; Canada NEOADJUVANT CANCER TREATMENT; China NEOADJUVANT CANCER TREATMENT; EP 13856989.2 - Method of Treating Solid Tumor w/Oncolytic Poliovirus licensed to Istari, a patent; HK 15112399.5 - Method of Treating Solid Tumor w/Oncolytic Poliovirus licensed to Istari, a patent; JP 2020-554198 NEOADJUVANT CANCER TREATMENT; PCT/US2019/025402 NEOADJUVANT CANCER TREATMENT; South Korea 10-2020-7031272 NEOADJUVANT CANCER TREATMENT; US 15/428510 - Method of Treating Solid Tumor w/Oncolytic Poliovirus licensed to Istari, a patent; US 16/086,735 SEQUENTIAL ANTI-CANCER TREATMENT; US 16/505,771 ONCOLYTIC POLIOVIRUS FOR HUMAN TUMORS; US 17/016,699 ONCOLYTIC POLIOVIRUS FOR HUMAN TUMORS; US 17/044,645 NEOADJUVANT CANCER TREATMENT; US 62/651,470; US 62/823,277 NEOADJUVANT CANCER TREATMENT
 
Seunggu Jude Han
No Relationships to Disclose
 
Santosh Kesari
Stock and Other Ownership Interests - Curtana; Praesidia; xcures
Honoraria - Jubilant Biosys; Pyramid Biosciences
Consulting or Advisory Role - biocept; iCAD; xcures
Research Funding - AIVITA Biomedical, Inc. (Inst); Bayer (Inst); Biocept (Inst); Blue Earth Diagnostics (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Caris MPI (Inst); cns pharmaceuticals (Inst); EpicentRx (Inst); Lilly (Inst); Oblato (Inst); Orbus therapeutics (Inst)
 
Sudhir Madduri Karanam
Employment - Medicenna
Stock and Other Ownership Interests - Medicenna
 
Rosemina Merchant
Employment - Medicenna
Leadership - Medicenna
Stock and Other Ownership Interests - Medicenna
 
Joanna J. Phillips
No Relationships to Disclose
 
Minh D To
Employment - Medicenna
Stock and Other Ownership Interests - Medicenna; Northern Biologics
Patents, Royalties, Other Intellectual Property - University of California San Franciso
 
Michael A. Vogelbaum
Stock and Other Ownership Interests - Infusion Therapeutics
Consulting or Advisory Role - Midatech Pharma; Olympus; SERVIER
Research Funding - Celgene (Inst); Denovo Biopharma (Inst); Infusion Therapeutics (Inst); Oncosynergy (Inst)
Patents, Royalties, Other Intellectual Property - Patent for drug delivery devices, assigned to Moffitt Cancer Center.; Patents for drug delivery devices for the brain
 
Frank Vrionis
No Relationships to Disclose
 
Fahar Merchant
Employment - Medicenna
Leadership - Medicenna
Stock and Other Ownership Interests - Medicenna
Patents, Royalties, Other Intellectual Property - Medicenna
 
Nicholas A. Butowski
Employment - University of California, San Francisco
Stock and Other Ownership Interests - Cordance; Cordance
Consulting or Advisory Role - IN8Bio; Ipsen; KIYATEC; Novartis; Plus Therapeutics; VBI Vaccines
Research Funding - Abbvie (Inst); Amgen; Amgen (Inst); Arbor Pharmaceuticals (Inst); BeiGene (Inst); BeiGene (Inst); BioMimetix (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); EpicentRx; Five Prime Therapeutics; Ipsen; Istari (Inst); KIYATEC (Inst); Medicenna; Merck; Oncoceutics (Inst); Orbus Therapeutics; Tocagen (Inst)